Dermal xenobiotic metabolism: a comparison between native human skin, four in vitro skin test systems and a liver system.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 24943921)

Published in Skin Pharmacol Physiol on June 13, 2014

Authors

Christian Wiegand1, Nicola J Hewitt, Hans F Merk, Kerstin Reisinger

Author Affiliations

1: Henkel AG & Co. KGaA, Düsseldorf, Germany.

Articles by these authors

Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol (2013) 3.00

Polybrominated diphenyl ethers induce developmental neurotoxicity in a human in vitro model: evidence for endocrine disruption. Environ Health Perspect (2010) 1.75

Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions. Ann Allergy Asthma Immunol (2005) 1.52

A skin-like cytochrome P450 cocktail activates prohaptens to contact allergenic metabolites. J Invest Dermatol (2006) 1.46

Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol (2006) 1.43

PPARalpha activators inhibit vascular endothelial growth factor receptor-2 expression by repressing Sp1-dependent DNA binding and transactivation. Circ Res (2003) 1.33

Expression of transcription factor Oct-4 and other embryonic genes in CD133 positive cells from human umbilical cord blood. Thromb Haemost (2004) 0.99

Allelic loss underlies type 2 segmental Hailey-Hailey disease, providing molecular confirmation of a novel genetic concept. J Clin Invest (2004) 0.96

Fluid shear stress-induced transcriptional activation of the vascular endothelial growth factor receptor-2 gene requires Sp1-dependent DNA binding. FEBS Lett (2003) 0.95

Phenotype diversity in familial cylindromatosis: a frameshift mutation in the tumor suppressor gene CYLD underlies different tumors of skin appendages. J Invest Dermatol (2002) 0.95

Linkage disequilibrium between tumor necrosis factor (TNF)-alpha-308 G/A promoter and TNF-beta NcoI polymorphisms: Association with TNF-alpha response of granulocytes to endotoxin stimulation. Crit Care Med (2003) 0.95

A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: eye irritation. Regul Toxicol Pharmacol (2009) 0.94

State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology. ALTEX (2014) 0.94

Interleukin-6-type cytokines upregulate expression of multidrug resistance-associated proteins in NHEK and dermal fibroblasts. J Invest Dermatol (2005) 0.93

Fluoroquinolone-associated anaphylaxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluoroquinolones and occurrence after first-ever use. Drug Saf (2006) 0.92

Aryl hydrocarbon receptor repressor (AhRR) function revisited: repression of CYP1 activity in human skin fibroblasts is not related to AhRR expression. J Invest Dermatol (2012) 0.92

Skin retinoid concentrations are modulated by CYP26AI expression restricted to basal keratinocytes in normal human skin and differentiated 3D skin models. J Invest Dermatol (2006) 0.92

Transcriptional profiling identifies an interferon-associated host immune response in invasive squamous cell carcinoma of the skin. Int J Cancer (2008) 0.91

Clinical comparison of the efficacy and tolerability of once daily Canesten with twice daily Nizoral (clotrimazole 1% cream vs. ketoconazole 2% cream) during a 28-day topical treatment of interdigital tinea pedis. Mycoses (2002) 0.89

Gene expression profiling of lichen planus reflects CXCL9+-mediated inflammation and distinguishes this disease from atopic dermatitis and psoriasis. J Invest Dermatol (2007) 0.89

Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: activating enzymes (Phase I). Exp Dermatol (2012) 0.88

Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro. J Invest Dermatol (2005) 0.88

IL-31 receptor alpha expression in epidermal keratinocytes is modulated by cell differentiation and interferon gamma. J Invest Dermatol (2008) 0.87

Delayed-type hypersensitivity reaction to paraphenylenediamine is mediated by 2 different pathways of antigen recognition by specific alphabeta human T-cell clones. J Allergy Clin Immunol (2002) 0.87

Generation of proliferating human hepatocytes using Upcyte® technology: characterisation and applications in induction and cytotoxicity assays. Xenobiotica (2012) 0.87

Differential expression of influx and efflux transport proteins in human antigen presenting cells. Exp Dermatol (2008) 0.85

Allergen microarrays: a novel tool for high-resolution IgE profiling in adults with atopic dermatitis. Eur J Dermatol (2009) 0.85

Calcium pantothenate modulates gene expression in proliferating human dermal fibroblasts. Exp Dermatol (2009) 0.84

Xenobiotic metabolism capacities of human skin in comparison with a 3D-epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: phase II enzymes. Exp Dermatol (2012) 0.84

Expression and function of macrophage migration inhibitory factor in the pathogenesis of UV-induced cutaneous nonmelanoma skin cancer. Photochem Photobiol (2012) 0.83

Anaphylaxis induced by glucocorticoids. J Am Board Fam Pract (2005) 0.83

Intratumoral induction of thymidylate synthase mRNA by 5-FU in colorectal cancer patients: association with survival. Oncol Rep (2003) 0.82

The reconstructed skin micronucleus assay (RSMN) in EpiDerm™: detailed protocol and harmonized scoring atlas. Mutat Res (2010) 0.82

MnSOD polymorphisms in sensitized patients with delayed-type hypersensitivity reactions to the chemical allergen para-phenylene diamine: a case-control study. Toxicology (2005) 0.82

Evaluation of chemicals requiring metabolic activation in the EpiDerm™ 3D human reconstructed skin micronucleus (RSMN) assay. Mutat Res (2012) 0.82

P-glycoprotein (ABCB1) expression in human skin is mainly restricted to dermal components. Exp Dermatol (2011) 0.81

Xenobiotic metabolism in human skin and 3D human skin reconstructs: a review. Curr Drug Metab (2007) 0.81

Species-specific differential AhR expression protects human neural progenitor cells against developmental neurotoxicity of PAHs. Environ Health Perspect (2010) 0.81

A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: genotoxicity. A COLIPA analysis. Regul Toxicol Pharmacol (2010) 0.81

International prevalidation studies of the EpiDerm 3D human reconstructed skin micronucleus (RSMN) assay: transferability and reproducibility. Mutat Res (2010) 0.81

Optimization of upcyte® human hepatocytes for the in vitro micronucleus assay. Mutat Res (2013) 0.80

Categorization of chemicals according to their relative human skin sensitizing potency. Dermatitis (2014) 0.80

Allergological approach to drug hypersensitivity reactions. J Dtsch Dermatol Ges (2008) 0.80

Prospective randomized study on the efficacy of blue light in the treatment of psoriasis vulgaris. Dermatology (2011) 0.79

Prediction of hepatic clearance using cryopreserved human hepatocytes: a comparison of serum and serum-free incubations. J Pharm Pharmacol (2006) 0.79

Differential in vitro hepatotoxicity of troglitazone and rosiglitazone among cryopreserved human hepatocytes from 37 donors. Chem Biol Interact (2002) 0.79

Characterization of a novel standardized human three-dimensional skin wound healing model using non-sequential fractional ultrapulsed CO2 laser treatments. Lasers Surg Med (2015) 0.79

The "strip" patch test: results of a multicentre study towards a standardization. Arch Dermatol Res (2004) 0.78

In vitro detection of contact allergens: development of an optimized protocol using human peripheral blood monocyte-derived dendritic cells. Toxicol In Vitro (2010) 0.78

Comet assay in reconstructed 3D human epidermal skin models--investigation of intra- and inter-laboratory reproducibility with coded chemicals. Mutagenesis (2013) 0.78

The molecular basis of porphyria cutanea tarda in Chile: identification and functional characterization of mutations in the uroporphyrinogen decarboxylase gene. Exp Dermatol (2004) 0.78

Pilot study: optical coherence tomography as a non-invasive diagnostic perspective for real time visualisation of onychomycosis. Mycoses (2009) 0.78

Applicability and robustness of the hen's egg test for analysis of micronucleus induction (HET-MN): results from an inter-laboratory trial. Mutat Res (2012) 0.77

An estimate of the number of hepatocyte donors required to provide reasonable estimates of human hepatic clearance from in vitro experiments. Drug Metab Lett (2007) 0.77

Active transport of contact allergens in human monocyte-derived dendritic cells is mediated by multidrug resistance related proteins. Arch Biochem Biophys (2011) 0.77

Use of human in vitro skin models for accurate and ethical risk assessment: metabolic considerations. Toxicol Sci (2013) 0.77

The effect of EGF and the comitogen, norepinephrine, on the proliferative responses of fresh and cryopreserved rat and mouse hepatocytes. Cryobiology (2006) 0.77

Prospective Randomized Long-Term Study on the Efficacy and Safety of UV-Free Blue Light for Treating Mild Psoriasis Vulgaris. Dermatology (2015) 0.77

A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: skin irritation. Regul Toxicol Pharmacol (2009) 0.77

Microarray-based detection of specific IgE against recombinant ω-5-gliadin in suspected wheat-dependent exercise-induced anaphylaxis. Eur J Dermatol (2012) 0.76

Digenic inheritance of mutations in the coproporphyrinogen oxidase and protoporphyrinogen oxidase genes in a unique type of porphyria. J Invest Dermatol (2011) 0.76

Reactivity of in vitro activated human T lymphocytes to p-phenylenediamine and related substances. Contact Dermatitis (2008) 0.76

Classification and labeling of industrial products with extreme pH by making use of in vitro methods for the assessment of skin and eye irritation and corrosion in a weight of evidence approach. Toxicol In Vitro (2011) 0.76

Prospective, Randomized Study on the Efficacy and Safety of Local UV-Free Blue Light Treatment of Eczema. Dermatology (2016) 0.76

Elicitation response characteristics to mono- and to N,N'-diacetyl-para-phenylenediamine. Contact Dermatitis (2008) 0.76

Radical resection of giant congenital melanocytic nevus and reconstruction with meek-graft covered integra dermal template. Dermatol Surg (2003) 0.76

Characterization of enzyme activities of Cytochrome P450 enzymes, Flavin-dependent monooxygenases, N-acetyltransferases and UDP-glucuronyltransferases in human reconstructed epidermis and full-thickness skin models. Toxicol In Vitro (2011) 0.76

[Glucocorticoid allergy]. J Dtsch Dermatol Ges (2011) 0.75

Cutaneous metabolic activation of carvoxime, a self-activating, skin-sensitizing prohapten. Chem Res Toxicol (2009) 0.75

Lymphocyte transformation test as a diagnostic test in allergic contact dermatitis. Contact Dermatitis (2005) 0.75

Effects of photodynamic therapy evaluated in a novel three-dimensional squamous cell carcinoma organ construct of the skin. Photochem Photobiol (2008) 0.75

A novel strategy for ADME screening of prodrugs: combined use of serum and hepatocytes to integrate bioactivation and clearance, and predict exposure to both active and prodrug to the systemic circulation. J Pharm Sci (2014) 0.75

[Hair diseases]. Hautarzt (2009) 0.75

Unilateral facial telangiectases suggest type 1 segmental manifestation of Osler-Rendu-Weber syndrome in an 11-year-old boy. Eur J Dermatol (2004) 0.75

Onychomycosis in a diabetic patient due to Trichophyton gallinae. Mycoses (2006) 0.75

Main highlights of International Dermatotoxicology Symposium, Netherlands-Vaals. Skin Pharmacol Physiol (2010) 0.75

Active transport of contact allergens and steroid hormones in epidermal keratinocytes is mediated by multidrug resistance related proteins. J Invest Dermatol (2010) 0.75

Statistical analysis of the hen's egg test for micronucleus induction (HET-MN assay). Mutat Res (2013) 0.75

Effects of the genotoxic compounds, benzo[a]pyrene and cyclophosphamide on phase 1 and 2 activities in EpiDerm™ models. Xenobiotica (2011) 0.75

Knockdown of lecithin retinol acyltransferase increases all-trans retinoic acid levels and restores retinoid sensitivity in malignant melanoma cells. Exp Dermatol (2014) 0.75

Efficacy of 4 weeks topical bifonazole treatment for onychomycosis after nail ablation with 40% urea: a double-blind, randomized, placebo-controlled multicenter study. Mycoses (2013) 0.75

Eye irritation potential: usefulness of the HET-CAM under the Globally Harmonized System of classification and labeling of chemicals (GHS). Regul Toxicol Pharmacol (2011) 0.75

Evaluation of the sensitizing potential of antibiotics in vitro using the human cell lines THP-1 and MUTZ-LC and primary monocyte-derived dendritic cells. Toxicol Appl Pharmacol (2012) 0.75

Dual porphyrias revisited. Exp Dermatol (2006) 0.75

Severe generalised rhabdomyolysis with fatal outcome associated with isotretinoin. Int J Legal Med (2012) 0.75

LRAT overexpression diminishes intracellular levels of biologically active retinoids and reduces retinoid antitumor efficacy in the murine melanoma B16F10 cell line. Skin Pharmacol Physiol (2015) 0.75

Value of component based diagnostics in IgE-mediated hymenoptera sting reactions. Cutan Ocul Toxicol (2011) 0.75

Allergic contact dermatitis from phenylephrine in eyedrops. Am J Contact Dermat (2002) 0.75

[Emergency checklist: Anaphylaxis]. MMW Fortschr Med (2014) 0.75

Multiple patch-test reactions: a pilot evaluation of a combination approach to visualize patterns of multiple sensitivity in patch-test databases and a proposal for a multiple sensitivity index. Am J Contact Dermat (2003) 0.75